Real-time enrollment status for this uveal melanoma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT06581406 |
| Recruiting Status | Recruiting |
| Condition | Uveal Melanoma |
| Phase | Clinical Trial |
| Target Enrollment | 280 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Replimune Inc. |
| Last Updated on CT.gov | April 2, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT06581406 is currently recruiting participants. This clinical trial study for uveal melanoma is actively seeking new participants at 23 locations across the United States. The study is sponsored by Replimune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06581406 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06581406 was last updated 2 weeks ago (April 2, 2026). HelloStudys verifies this status automatically.